Consolidated Planning Corp
- SEC CIK
- 0001805250
- Latest filing
- Jul 24, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Consolidated Planning Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 29,042
- Value
- $2.64M
- % of portfolio
- 0.4%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 29,042 | $2.64M | 0.4% | +976+3.5% | Added | Holders |
| Q1 2026 | 28,066 | $2.88M | 0.5% | +7,567+36.9% | Added | Holders |
| Q4 2025 | 20,499 | $2.57M | 0.3% | +1,672+8.9% | Added | Holders |
| Q3 2025 | 18,827 | $2.52M | 0.3% | +17,104+992.7% | Added | Holders |
| Q2 2025 | 1,723 | $234.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,723 | $228.6K | <0.1% | −512−22.9% | Reduced | Holders |
| Q4 2024 | 2,235 | $252.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 2,235 | $254.8K | <0.1% | −30−1.3% | Reduced | Holders |
| Q2 2024 | 2,265 | $235.4K | <0.1% | +362+19.0% | Added | Holders |
| Q1 2024 | 1,903 | $216.3K | <0.1% | −223−10.5% | Reduced | Holders |
| Q4 2023 | 2,126 | $234.0K | <0.1% | −94−4.2% | Reduced | Holders |
| Q3 2023 | 2,220 | $215.0K | <0.1% | −5,960−72.9% | Reduced | Holders |
| Q2 2023 | 8,180 | $679.4K | 0.1% | −34,434−80.8% | Reduced | Holders |
| Q1 2023 | 42,614 | $4.32M | 1.1% | +29,855+234.0% | Added | Holders |
| Q4 2022 | 12,759 | $1.40M | 0.4% | −2,669−17.3% | Reduced | Holders |
| Q3 2022 | 15,428 | $1.49M | 0.5% | −3,726−19.5% | Reduced | Holders |
| Q2 2022 | 19,154 | $2.08M | 0.7% | +5,786+43.3% | Added | Holders |
| Q1 2022 | 13,368 | $1.58M | 1.1% | +5,659+73.4% | Added | Holders |
| Q4 2021 | 7,709 | $1.08M | 0.7% | +7,405+2,435.9% | Added | Holders |
| Q3 2021 | 304 | $36.0K | <0.1% | +304 | New | Holders |